混合纳米凝药物输送系统:通过瘤组织编辑改变瘤微环境
Theodora Katopodi1, Savvas Petanidis1,2, George Floros3
1Laboratory of Medical Biology and Genetics, Department of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Cells
|June 19, 2024
概括
纳米凝提供了先进的药物输送系统,具有增强的稳定性和药物载荷能力. 这些纳米平台可以实现向治疗和刺激反应药物释放,以改善癌症治疗结果.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 制药科学 制药科学
背景情况:
- 纳米凝代表了一个有前途的药物输送平台,因为它们的稳定性和多功能药物装载能力,用于各种药物.
- 复合纳米凝作为多功能系统起作用,能够携带药物,基因和诊断剂,用于神经应用.
研究的目的:
- 探索基于纳米凝的药物输送系统在先进癌症治疗中的潜力.
- 突出纳米凝在刺激反应性药物释放和治疗剂的向输送中的作用.
主要方法:
- 设计和合成纳米凝平台用于药物封装.
- 纳入向配体,以增强瘤部位的积累.
- 在瘤微环境 (TME) 内的控制药物释放的刺激响应纳米凝的开发.
主要成果:
- 纳米凝证明了对疏水性和疏水性药物的有效负载.
- 刺激响应纳米凝能够精确释放化疗/免疫疗法药物,重编程TME细胞.
- 带功能化纳米凝提高了向药物输送和治疗疗效.
结论:
- 多功能纳米凝为向药物输送和组合癌症治疗提供了一个复杂的平台.
- 基于纳米凝的系统通过改善药物分发和治疗结果来提高癌症治疗的精度.
- 先进的纳米凝具有瘤组织编辑特性,为新的免疫治疗策略铺平了道路.
更多相关视频
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.7K
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
2.5K
相关概念视频
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
01:27Tumor Immunotherapy
511
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511